-
34 pharmaceutical and biological companies were investigated by institutions, and 10 shares were investigated by more than 20 institutions
Time of Update: 2023-01-01
Among them, the domestic IVD company Dirui Medical has attracted a lot of institutional attention, in the past 5 trading days (November 29 to December 5), a total of 143 institutions have been surveyed, and the new closing price of the stock is 26.
-
The study found "there may be a biological and genetic overlap" between carpal tunnel syndrome and migraine
Time of Update: 2023-01-01
" A study in the December issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgery (ASPS), reported that patients who underwent surgery for carpal tunnel syndrome and other upper extremity nerve compression syndromes were more likely to be diagnosed with migraine.
-
The clinical trial application of the long-term biological pan-FGFR kinase inhibitor KIN-3248 was approved
Time of Update: 2022-12-30
js?cdnversion='+~(-new Date()/36e5)];Recently, Jingjiu Biologics announced that the clinical trial application of KIN-3248, a new generation of FGFR inhibitor, has obtained the implied license of the Center for Drug Review (CDE) of the National Medical Products Administration, and intends to carry out clinical research in Chinese mainland.
-
The application of biological aviation coal in China has achieved new breakthroughs
Time of Update: 2022-12-30
(Reporter Yang Jie) From: China Securities News Return to Sankei homepage >> The application of biological aviation coal in China has achieved new breakthroughs Welcome here On December 19, Sinopec announced that it recently completed its first international flight Chinese mainland commercial cargo flight using sustainable aviation fuel.
-
Why is the new crown rampant in winter? Scientists reveal the first biological mechanism!
Time of Update: 2022-12-30
037brief summaryUpper respiratory tract infections vary seasonally, especially in winter, and infection rates increase because cold exposure impairs antiviral immune defense mediated by nasal epithelial EVs, which may be achieved by downregulating TLR3-dependent EV secretion and miR-17 abundance, and reducing TLR3-dependent EV surface receptor protein expression.
-
2022ASH Express; Kangfeng Biologics products were recognized as breakthrough devices by the FDA; Henlius is licensed by Yilian Biologics ADC platform
Time of Update: 2022-12-30
Pharmacis SelectionPharmacis SelectionASH 2022: Ascentage Pharma announces latest data on APG-2575 for the treatment of CLL/SLL patientsASH 2022: Ascentage Pharma announces latest data on APG-2575 for the treatment of CLL/SLL patientsAscentage Pharma Group announced that APG-2575 alone or in combination with CALQUENCE (acalabrutinib) and rituximab in the treatment of patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is initially available.
-
The mouse genome database is included in the global core biological data resource
Time of Update: 2022-12-30
Guy Cochrane, Executive Director of GBC, said: "The announcement of this list will bring funders and biological data resources together to develop sustainability models that meet their needs and ensure that these data resources can continue to support the global research community.
-
The pharmaceutical and biological industry has performed well, and 6 pharmaceutical companies have achieved good results in 2022
Time of Update: 2022-12-30
3% over the previous year; It is expected that the net profit attributable to shareholders of listed companies from January to December 2022 will be 120 million yuan to 130 million yuan, an increase of 8.
-
Effects of 4 different extraction methods of FSHW on physicochemical properties and biological activity of yam peel polysaccharides
Time of Update: 2022-12-30
To improve the added value of yam peels, the key is to find a fast, convenient and efficient extraction method, and in this study, four different extraction methods: hot water extraction (W), acid extraction (HA), hot compressed water extraction (HCW) and enzyme extraction (EAE) were used to investigate the yield, total sugar content, physicochemical properties, antioxidant and hypoglycemic activities of polysaccharides, and selected the best method for extracting polysaccharides for the food industry.
-
China has achieved the first flight of green international cargo of biological aviation coal
Time of Update: 2022-12-29
(Photo courtesy of Sinopec)Recently, Chinese mainland first commercial cargo flight using sustainable aviation fuel completed its maiden flight.
(Photo courtesy of Sinopec)Recently, Chinese mainland first commercial cargo flight using sustainable aviation fuel completed its maiden flight.
-
Sumitomo Chemical announced that it will launch new molecular products, including biologics, in Argentina in 2023
Time of Update: 2022-12-29
Lucas Díaz Panizza, marketing manager at Sumitomo Chemical, revealed in an interview with AgroPages that in 2023, the company will begin launching a range of new molecular products, including biologics, for the Argentine market and the region.
-
Cell: Cao Peng's team at the Beijing Institute of Biological Sciences reveals the neurobiological mechanism of the "nausea-vomiting" response
Time of Update: 2022-12-04
Effects of specific activation of DVC Tac1+→rVRG or DVC Tac1+→LPB neural circuits on SEA-induced nausea and retching responses In addition to food toxins, chemotherapy drugs, such as cisplatin and doxorubicin, can also trigger nausea and gagging.
-
Canada approved the registration of the fungicide pyridinamide and two biological control products
Time of Update: 2022-11-25
2. Microbial pest control agent Foretryx Canada will approve the sale and use of microbial pest control agents (MCPAs) containing active ingredients in the original drug, including Trichoderma asperellum ICC 012 stock, Trichoderma gamsii ICC 080 and Foretryx.
-
Junheng Biologics' low-condensation HVO products made their maiden voyage to Europe
Time of Update: 2022-11-25
The maiden voyage of 10,000 tons of low-condensing HVO products in Europe was directly delivered to Europe through cooperative customer Trafigura Group of the Netherlands, with the first order worth 23 million US dollars.
-
Guidelines Express Korean clinical practice guidelines for the treatment of moderate to severe Crohn's disease with biologics
Time of Update: 2022-11-25
Statement 2: For patients with moderate to severe CD who achieve clinical response or remission with infliximab, adalimumab, vederolizumab, or ustekinumab, we suggest the same biologic agents for maintenance therapy (strongly recommended, moderate-quality evidence).